Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermocosmetica is a leading Australian specialty pharmaceutical company focused on the dermatology and medical aesthetics sectors. The company specializes in the distribution, marketing, and clinical support of high-performance skin health solutions, including medical-grade cosmeceuticals and aesthetic devices. Their portfolio features globally recognized brands such as Mesoestetic, Universkin, and Stratpharma, addressing a wide range of clinical indications including hyperpigmentation, acne, and scar management. Dermocosmetica operates primarily in the Asia-Pacific region, providing healthcare professionals with evidence-based products and comprehensive training. The company is recognized for its commitment to bringing innovative dermatological technologies to the Australian and New Zealand markets. Through its strategic partnerships, Dermocosmetica offers a diverse range of therapeutic modalities, from topical small molecules to advanced medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermocosmetica.